Y. Okamoto et al. / Tetrahedron 56 (2000) 5813±5818
5817
ATP was given by the following equation: (12[ADP]sample
[ADP]control)£100%, [ADP] indicates the peak area of ADP.
/
Anal. Calcd for C22H23Br4N3O7: C, 34.72; H, 3.05; N,
5.52%. Found: C, 34.73; H, 2.80; N, 5.23%.
Ianthesine C (3). Yellow powder; mp 2008C (dec.) (pre-
cipitated from H2O±DMSO); [a]2D6 293 (c 0.86, DMSO);
IR (KBr) nmax 3700±2500 (br), 1660, 1584, 1541, 1257,
1218, 1183, 1047, and 990 cm21; UV (MeOH±0.5%
DMSO) lmax 231 (e 26900) and 283 (11900) nm; CD
Collection, extraction, and isolation
The sponge Ianthella sp. (1.8 kg wet weight), collected at a
depth of 12 m in the Great Barrier Reef, Australia, was
homogenized in MeOH (4 l), and the resulting mixture
was then ®ltered. The residue was washed three times
with MeOH (2 l). The ®ltrates were combined and concen-
trated to 1 l, and the resulting aqueous residue was extracted
three times with EtOAc (1.5 l). The combined EtOAc layers
were evaporated to give a pale brown powder (14.4 g),
which inhibited Na,K-ATPase with an IC50 of 10 mg/ml.
A portion (4.0 g) of the EtOAc extract was chromato-
graphed on silica gel (200 g) with CHCl3±MeOH±H2O
(7:3:1 lower phase, 65:35:10 lower phase, and then 6:4:1)
to give seven fractions. The third fraction was pure 1
[182 mg, Rf0.43 on silica gel TLC developed with
CHCl3±MeOH±H2O (65:35:10 lower phase)]. The second
fraction (687 mg) was chromatographed on silica gel
(137 g) with CHCl3±MeOH±H2O (10:3:1 lower phase).
The fractions containing 1, 2 (Rf0.33 under the same
conditions), and 3 (Rf0.28 under the same conditions)
were combined and then chromatographed on silica gel
(63 g) to give 1 (163 mg), 2 (63 mg), and 3 (94 mg) as
powders. An other portion (3.0 g) of the above EtOAc
extract was chromatographed on silica gel in the same
manner to give seven fractions. The third fraction
(503 mg) contained 1, 2, and 3. The fourth fraction
(990 mg) contained iantheran A15 (Rf0.37 under the
same conditions) as the major component. The ®fth fraction
(322 mg) containing 4 (Rf0.13 under the same conditions)
was chromatographed on silica gel (97 g) with CHCl3±
MeOH±H2O (7:3:1 lower phase and then 65:35:10 lower
phase) to give four fractions. A portion (41.4 mg) of the
third fraction (total 86.4 mg) was puri®ed by reversed-
phase HPLC [Develosil ODS-HG-5 (10 i.d.£250 mm,
Nomura Chemical) with MeOH±H2O (3:2) at a ¯ow rate
of 2.5 ml/min, detected at 254 nm] to give 4 (20 mg,
tR6.8 min) as a powder.
1
(MeOH) lext 252 nm (De 216.0), 289 (216.9); H and
13C NMR data, see Tables 1 and 2; FABMS (matrix:
glycerol), see Fig. 2. Anal. Calcd for C44H43Br8N6O16SNa:
C, 32.90; H, 2.70; N, 5.23%. Found: C, 32.48; H, 2.81; N,
4.84%.
Ianthesine D (4). Colorless powder; mp 1908C (dec.);
[a]2D5269 (c 0.19, MeOH); IR (KBr) nmax 3700±2500
(br), 1662, 1596, 1541, 1258, 1217, and 1046 cm21; UV
(MeOH) lmax 206 (e 53200), 220 (sh, 25000), and 282 nm
(6760); CD (MeOH) lext 254 nm (De 9.14), 289 (28.74);
1H and 13C NMR data, see Tables 1 and 2; FABMS (matrix:
glycerol) m/z 836, 838, 840, 842, and 844 (rel. int. 1:4:6:4:1)
(M2Na)2. Anal. Calcd for C22H22Br4N3O7SNa: C, 30.61;
H, 2.57; N, 4.87%. Found: C, 30.60; H, 2.53; N, 4.87%.
Degradation of ianthesine A (1)
A solution of 1 (10.7 mg) in 48% hydrobromic acid (1 ml)
was heated under re¯ux for 24 h. The resulting solution was
evaporated, and the residue was puri®ed by reversed-phase
HPLC [Develosil ODS-HG-5 (10 i.d.£250 mm), 33% aq.
MeOH, ¯ow rate 2.5 ml/min, detected at 210 nm] to afford
3,5-dibromo-N,N-dimethyltyrosine (3.9 mg, tR10 min) as
1
a white powder: H NMR (400 MHz, CD3OD) d 2.66 (s,
6H), 2.93 (m, 1H), 3.05 (m, 1H), 3.49 (m, 1H), and 7.41 (s,
2H). A solution of 3,5-dibromo-N,N-dimethyltyrosine
(3.9 mg) in MeOH±H2O (1:2) (1.0 ml) was stirred with
10% Pd±C (1.7 mg) under a hydrogen atmosphere at
room temperature for 1.5 h. After ®ltration, the ®ltrate
was evaporated to give a crude product, which was puri®ed
by reversed-phase HPLC [Develosil ODS-HG-5 (10
i.d.£250 mm), 33% aq. MeOH, ¯ow rate 2.5 ml/min,
detected at 210 nm] to afford N,N-dimethyltyrosine
(0.9 mg, tR5.7 min) as a white powder: [a]2D3273 (c
0.075, water); IR (KBr) nmax 3700±2500 (br), 1615, 1595,
1515, and 1250 cm21; 1H NMR (400 MHz, CD3OD) d 2.79
(s, 6H), 3.09 (dd, J6.9, 14.7 Hz, 1H), 3.22 (dd, J6.7,
14.7 Hz, 1H), 3.74 (dd, J6.7, 6.9 Hz, 1H), 6.73 (d,
J8.5 Hz, 2H), and 7.16 (d, J8.5 Hz, 2H); HRMS
(FAB) calcd for C11H16NO3 (M1H) m/z 210.1130, found
210.1146.
Ianthesine A (1). Colorless ®ne crystals; mp 154±1568C
(MeOH±H2O); [a]2D22118 (c 1.02, MeOH); IR (KBr)
nmax 3700±2300 (br), 1660, 1630, 1540, 1260, and
1045 cm21; UV (MeOH) lmax 210 (e 29500) and 283 nm
(7390); CD (MeOH) lext 248 nm (De 210.2), 285 (29.94);
1H and 13C NMR data, see Tables 1 and 2; FABMS (matrix:
thioglycerol) m/z 786, 788, 790, 792, and 794 (rel. int.
1:4:6:4:1) (M1H)1; HRMS (FAB) calcd for
C24H2879Br4N3O7 (M1H) m/z 785.8661, found 785.8649.
Anal. Calcd for C24H27Br4N3O7: C, 36.53; H, 3.45; N,
5.33%. Found: C, 36.53; H, 3.18; N, 5.23%.
The absolute stereochemistry was determined to be D by
chiral HPLC analysis [CHIRALPAK WH (4.6
i.d.£250 mm, Daicel Chemical), column temp. 508C,
0.25 mM CuSO4, ¯ow rate 1.0 ml/min, detected at
230 nm], in which the retention times of the authentic
samples of N,N-dimethyl-d and l-tyrosines19 were 13.3
and 25.4 min, respectively.
Ianthesine B (2). Colorless ®ne crystals; mp 154±1578C
(MeOH±H2O); [a]2D2297 (c 0.58, MeOH); IR (KBr)
nmax 3700±2300 (br), 1660, 1635, 1540, 1260, and
1045 cm21; UV (MeOH) lmax 207 (e 45400) and 283 nm
(7300); CD (MeOH) lext 248 nm (De 211.6), 284 (211.2);
1H and 13C NMR data, see Tables 1 and 2; FABMS (matrix:
thioglycerol) m/z 758, 760, 762, 764, and 766 (rel. int.
1:4:6:4:1) (M1H)1; HRMS (FAB) calcd for
C22H2479Br4N3O7 (M1H) m/z 757.8348, found 757.8359.
Degradation of ianthesine B (2)
A solution of 2 (10.3 mg) in 48% hydrobromic acid (1 ml)
was heated under re¯ux for 24 h. The resulting solution was